Clinical trial
Investigating the Effect of Renin-Angiotensin System Inhibitors in Addition to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Prospective Open-label Study
NCT04707508 is registered in ClinicalTrials.gov with Nantou Christian Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effect of Renin-Angiotensin System Inhibitors in Addition to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Prospective Open-label Study
- Lead sponsor
- Nantou Christian Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- November 29, 2019
- Enrollment
- 203 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.